Skip to main content
. 2022 Mar 15;12:824511. doi: 10.3389/fonc.2022.824511

Figure 1.

Figure 1

Annual trend for neurologic outcomes occurring in cancer patients treated with one or more immune checkpoint inhibitors (ICIs), categorized by years and administrated ICI treatments. The percentages of the first 3 treatments most involved in the neurological events collected each year are reported. * stands for the date 7th Feb 2021.